Published date: 11 August 2020

This notice was replaced on 2 September 2020

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 2 September 2020)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.

Contract summary


  • Medical equipments, pharmaceuticals and personal care products - 33000000

  • Laboratory, optical and precision equipments (excl. glasses) - 38000000

Location of contract


Value of contract

£100,000 to £125,000

Procurement reference

PURCON903 - TIPAL Spirometers

Published date

11 August 2020

Closing date

24 August 2020

Closing time


Contract start date

12 October 2020

Contract end date

12 October 2020

Contract type

Supply contract

Procedure type

Open (non-OJEU)

Any interested supplier may submit a tender in response to an opportunity notice.

Non-OJEU (Official Journal of the European Union) procedures are valued below a certain financial threshold.

Contract is suitable for SMEs?


Contract is suitable for VCSEs?



The UEA Norwich Clinical Trials Unit (NCTU) is a UKCRC registered trials unit and works with sites and institutes across the UK to deliver high quality studies. The Norfolk and Norwich University Hospitals (NNUH) NHS Foundation Trust is the Sponsor for the TIPAL trial and will be a party to the contract under this tender. NNUH have delegated certain Sponsor activities including the provision of study supplies to UEA through NCTU including the procurement of domiciliary spirometers, smart phones or tablets and data platforms to collect spirometry data for the trial.

The Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL) trial is a National Institute for Health Research Health Technology Assessment programme funded clinical trial. The full trial title is: the effectiveness and risks of treating people with idiopathic pulmonary fibrosis with the addition of lansoprazole (TIPAL): a randomised, placebo-controlled multi-centre clinical trial. The trial aims to recruit 298 patients across 30 sites in the UK with recruitment anticipated to commence from Autumn 2020 following revisions to the initial study design due to the impact of the covid-19 pandemic.

All documents required as part of your tender response should be submitted via the appropriate area of the In-Tend e-tendering portal (link below) by the Tender Response Deadline, as set out in the Timescales section of the ITT.

About the buyer

Contact name

Sonny Gardiner




01603 597489